# Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure

> **NCT06669169** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 288 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Jia Shen Tablet Placebo
- **DRUG:** Low dose Jia Shen Tablet
- **DRUG:** High dose Jia Shen Tablet

## Key facts

- **NCT ID:** NCT06669169
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 288 (ESTIMATED)
- **Last updated:** 2024-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06669169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06669169, "Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06669169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*